Skip to content

Insys Therapeutics, Inc.

CIK 0001516479

← back to feed
Revenue (TTM)
$73.35M
−10.8% YoY Q1 May 2019
Net Income (TTM)
−$202.06M
−51.8% YoY Q1 May 2019
EPS Diluted (TTM)
−$2.72
−51.2% YoY Q1 May 2019
Gross Margin
82.6%
Q1 May 2019
Operating Margin
-273.8%
Q1 May 2019
Net Margin
-275.5%
Q1 May 2019
Free Cash Flow (TTM)
−$10.34M
Q1 May 2019
Cash
$36.51M
Q1 May 2019
Total Debt
$0
Q1 May 2019
Shares Outstanding
74.57M sh
Q1 May 2019

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings